Authors
Latest:
How Rare Cannabinoids Are Disrupting the Pharmaceutical IndustryBy 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
Latest:
FDA Issues EUA for First Oral Antiviral Pill for COVID-19The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.
Latest:
NDA for Investigational Schizophrenia Treatment Submitted to FDAThe NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.
Latest:
Review: Harmful Excipients for Pediatric PatientsEvidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.
Latest:
Pharmacy Technicians Provide Patient Assistance With Oral OncolyticsPharmacy technicians can provide a great amount of value for patients navigating the financial toxicity of cancer treatment.
Latest:
Blood-Based Test Demonstrates High Sensitivity for Colorectal CancerA blood-based cell-free DNA (cfDNA) test was able to find patients at increased risk of colorectal cancer (CRC), advanced neoplasia, and advanced precancerous lesions.
Latest:
Protecting Our Most Vulnerable Through VaccinationFor more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.
Latest:
Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common ColdDespite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Latest:
New Advances in Breast Cancer TherapyBreast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.
Latest:
Two Eye Diseases Could Contribute to Common Blinding Eye ConditionThe study could lead to early diagnosis and treatment of age-related macular degeneration.
Latest:
Preventing Severe Respiratory Infections in ChildrenA refresher on best interventions for common respiratory disorders in children.
Latest:
Focus on DIR Fees: 3 Ways to Manage ThemWhen investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.
Latest:
Maximizing Adherence Packaging for Patient Health and Pharmacy GrowthIs adherence packaging technology a big investment for a community or independent pharmacy?
Latest:
OTC Drug Interaction Considerations in the Cough and Cold AisleOTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.
Latest:
Differentiate Your Pharmacy With Unique Product, Service OfferingsOffering services such as point-of-care testing and bundled products marketed as recovery kits can increase customer loyalty.
Latest:
Navigating Pediatric ADHD Medication ShortagesStimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Latest:
Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference ProductFindings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.
Latest:
Case Study: Treating Infants for Cannabis ExposureAs more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
Creating A Successful Social Media PresenceSocial media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.
Latest:
COVID-19 Vaccines: T Cell, Antibody Responses Demonstrated in CLLPatients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.
Latest:
Breaking Down the Numbers for Isotretinoin AEsRecent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.
Latest:
Biosimilars Are Bringing Affordability and AccessibilityLower costs, increased availability, and assistance programs are “game changers” for patients.
Latest:
Why Is There Such A Large Disparity In Who Meets Critera For Hepatitis B Treatment?Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.
Latest:
New Drug Review: Atogepant FDA-Approved for Migraine TreatmentOn September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.
Latest:
Basal Insulin Therapies for Diabetes ManagementDiana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Thomas C. Blevins, MD, ECNU, FACE, FNLA, review FDA-approved basal insulins for the management of diabetes.
Latest:
DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in AdultsThis new drug utilizes the bactericidal properties of taurolidine and the bloodthinning effects of heparin to maintain catheter patency.
Latest:
Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget CutsWith the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.
